* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on May 11.
* The Solana Beach California-based company is expected to
report
a 3.8% increase in revenue to $4.183 million from $4.03 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 20 cents per share. For the same quarter last
year, the company reported a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18.5, above its last closing price of $7.38.
This summary was machine generated May 10 at 02:04 GMT. All
figures in US dollars unless otherwise stated